2015American Association of Bovine Practitioners Conference ProceedingsOpen access

Comparison of serum IgG half lives in dairy calves fed colostrum, colostrum replacer, or administered with intravenous plasma

J. M. Murphy, Jill V. Hagey, Munashe Chigerwe

Open full text 1 citations

Abstract

The cotyledonary placenta allows minimal transfer of immunoglobulins from the cow to the fetus during pregnancy. Consequently calves are born hypogammaglobulinemic, thus making it essential to ingest and absorb colostral immunoglobulins to acquire passive immunity. Therefore, the half-life of maternally derived colostral immunoglobulin G (IgG) in dairy calves is important in the development ofthe calf immune system as well as determination of the age at which to vaccinate the calf without interference from the maternally derived IgG. Half-life of maternally derived colostral IgG is estimated to be 20 days in dairy calves. In clinical settings, bovine plasma is used as part of treatment of sick calves that require additional immunity via plasma administration. Currently, no studies have evaluated the half-life of colostrum replacer derived IgG or plasma derived IgG in dairy calves. We hypothesized that the half-life of maternally derived IgG has a significantly different half-life compared to colostrum replacer derived or plasma derived IgG in dairy calves. The aims of this study were to determine the half lives of IgG derived from colostrum, colostrum replacer or plasma in dairy calves.

About this research paper

What this paper is about

The cotyledonary placenta allows minimal transfer of immunoglobulins from the cow to the fetus during pregnancy. Consequently calves are born hypogammaglobulinemic, thus making it essential to ingest and absorb colostral immunoglobulins to acquire passive immunity. Therefore, the half-life of maternally derived colostral immunoglobulin G (IgG) in dairy calves is important in the development ofthe calf immune system as well as determination of the age at which to vaccinate the calf without interference from the maternally derived IgG. Half-life of maternally derived colostral IgG is estimated to be 20 days in dairy calves. In clinical settings, bovine plasma is used as part of treatment of sick calves that require additional immunity via plasma administration. Currently, no studies have evaluated the half-life of colostrum replacer derived IgG or plasma derived IgG in dairy calves. We hypothesized that the half-life of maternally derived IgG has a significantly different half-life compared to colostrum replacer derived or plasma derived IgG in dairy calves. The aims of this study were to determine the half lives of IgG derived from colostrum, colostrum replacer or plasma in dairy calves.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The cotyledonary placenta allows minimal transfer of immunoglobulins from the cow to the fetus during pregnancy. Consequently calves are born hypogammaglobulinemic, thus making it essential to ingest and absorb colostral immunoglobulins to acquire passive immunity. Therefore, the half-life of maternally derived colostral immunoglobulin G (IgG) in dairy calves is important in the development ofthe calf immune system as well as determination of the age at which to vaccinate the calf without interference from the maternally derived IgG. Half-life of maternally derived colostral IgG is estimated to be 20 days in dairy calves. In clinical settings, bovine plasma is used as part of treatment of sick calves that require additional immunity via plasma administration. Currently, no studies have evaluated the half-life of colostrum replacer derived IgG or plasma derived IgG in dairy calves. We hypothesized that the half-life of maternally derived IgG has a significantly different half-life compared to colostrum replacer derived or plasma derived IgG in dairy calves. The aims of this study were to determine the half lives of IgG derived from colostrum, colostrum replacer or plasma in dairy calves.

Key concepts: Colostrum, Passive immunity, Antibody, Immunoglobulin G, Immune system, Fetus, Immunity, Placenta

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of serum IgG half lives in dairy calves fed colostrum, colostrum replacer, or administered with intravenous plasma — Research Paper | ScholarLens